FDA approves first app for substance abuse disorders
The US Food and Drug Administration (FDA) has approved a mobile app for therapeutic purposes for the first time.
The reSET app is a cognitive behavioural therapy-based tool intended to help those with substance use disorders remain abstinent and engaged with their outpatient therapy. It is approved for use in alcohol, cocaine, marijuana and stimulant substance use disorders.
Read more...